Letter to the Editor: Effectiveness of the Varicella Vaccine in Korea: Unresolved Issues
J Korean Med Sci
.
2021 Jul 12;36(27):e200.
doi: 10.3346/jkms.2021.36.e200.
Authors
BongKyoo Choi
1
2
,
Ji Hyeun Shin
3
,
Jee Eun Lee
4
,
Sang Baek Koh
5
Affiliations
1
Department of Research and Development, GC Pharma, Yongin, Korea.
2
Department of Medicine, University of California, Irvine, CA, USA. b.choi@gccorp.com.
3
Department of Pharmacovigilance, LSK Global PS, Seoul, Korea.
4
Department of Clinical and Regulatory Affairs, LG Chem Ltd, Seoul, Korea.
5
Department of Preventive Medicine, Wonju College of Medicine, Yonsei University, Wonju, Korea.
PMID:
34254478
PMCID:
PMC8275458
DOI:
10.3346/jkms.2021.36.e200
No abstract available
Publication types
Letter
Comment
MeSH terms
Chickenpox Vaccine*
Chickenpox* / epidemiology
Chickenpox* / prevention & control
Humans
Republic of Korea
Vaccines, Attenuated
Substances
Chickenpox Vaccine
Vaccines, Attenuated